Today: 19 May 2026
Salesforce stock sinks as ‘software-mageddon’ bites again — what to watch before earnings
6 February 2026
2 mins read

Salesforce stock sinks as ‘software-mageddon’ bites again — what to watch before earnings

New York, Feb 5, 2026, 17:37 EST — After-hours

  • On Thursday, Salesforce shares dropped 4.8%, ending the day just below $190
  • Software shares remained under pressure amid concerns that AI might upend subscription-based revenue models
  • All eyes now shift to Salesforce’s February 25 earnings report as the next key catalyst

Shares of Salesforce Inc (CRM) dropped 4.8% on Thursday, closing at $189.97. The stock swung between $187.80 and $200.40, with roughly 21.9 million shares changing hands.

Salesforce tumbled alongside other software-as-a-service (SaaS) stocks as investors dumped subscription cloud apps amid concerns that rapid advances in AI could undercut demand and pricing power. The S&P 500 software and services index plunged 4.6%, pushing its year-to-date loss to roughly 16.5%, deepening what traders are now dubbing a “software-mageddon.” Dave Harrison Smith, CIO at Bailard, called it a “sell-everything mindset,” while Reuters reported rising short interest in mid- and large-cap software names. Reuters

The stock plunged about $9.55, ranking among the top decliners on the Dow as it fell over 500 points. Salesforce and Amazon alone shaved roughly 117 points from the price-weighted index, according to MarketWatch’s analysis.

The selloff has spread worldwide, as investors in Europe and Asia offload software stocks while weighing if new AI tools can replace tasks traditionally handled by costly software suites. A Guardian market live blog linked this week’s drop to renewed excitement about Anthropic’s AI offerings for legal work.

Salesforce announced Wednesday it will report fourth-quarter and full-year fiscal 2026 results on Feb. 25, after the U.S. market closes. A conference call is set for 5 p.m. ET that day. Traders are now focused on whether the company’s AI initiatives are moving beyond pilot stages to actual paid adoption.

On Thursday, Salesforce released its annual Connectivity Benchmark Report, revealing that companies currently use an average of 12 AI agents and anticipate that figure will jump 67% over the next two years. Andrew Comstock, a MuleSoft executive, emphasized that success doesn’t come from the number of agents deployed but from how they’re governed and coordinated. Deloitte’s Kurt Anderson stressed the importance of “moving from simply deploying agents to operationalizing them at scale.” Salesforce

Salesforce’s Agentforce 360 made waves in customer marketing this week. LIV Golf announced its broadcasts will feature an AI “Agent Caddie” called Chip, delivering predictive shot outcomes and player stats straight to on-air analysts. Salesforce

Some bulls on Wall Street are already sniffing out a bottom. Wedbush analyst Dan Ives dismissed the sector’s selloff as a “garage sale,” telling Business Insider that investors are fixated on a near-term “doomsday scenario.” He remains bullish on Salesforce, keeping it on his buy list with a $375 price target. The stock has fallen more than 21% so far this year, he noted.

Value investors are showing interest, at least on paper. Barron’s reports that Salesforce is now trading with a forward price-to-earnings ratio below 15. This valuation, based on expected profits, is not only lower than its historical norm but also undercuts the broader S&P 500.

Yet what comes next hinges on the data, not the storylines. Should Salesforce’s guidance fall short or clients delay major CRM deployments, shares might face steeper declines—especially as discussions around AI disruption continue to expand.

Traders are now focused on whether software stocks can find footing as Friday’s session unfolds and if the recent selloff prompts more analysts to lower their estimates. Salesforce’s next major event comes Feb. 25, when it releases earnings after the market closes and fields investor questions about demand trends and its AI strategy.

Stock Market Today

  • How Many British American Tobacco Shares to Earn £6,581 Annual Passive Income?
    May 19, 2026, 5:16 AM EDT. British American Tobacco (LSE: BATS) offers a strong dividend yield, projected at 5.4% this year and rising to 5.8% by 2028. A £20,000 investment could buy 406 shares, generating £15,671 in dividends over 10 years and £93,470 over 30 years with dividends reinvested. This could grow to an annual income of £6,581 after 30 years, leveraging dividend compounding. Despite recent price gains, discounted cash flow analysis suggests the stock is 31% undervalued, with a fair value of £71.36 versus the current £49.24 price. Risks include declining cigarette volumes and increasing regulation, but profit growth is expected at about 4.1% annually through 2028. Overall, British American Tobacco remains a dependable choice for passive income investors seeking FTSE 100 heavyweights.

Latest articles

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

19 May 2026
New York, May 19, 2026, 05:03 EDT GeoVax Labs shares closed Monday at $2.21, up 79.7%, after the small vaccine developer announced a $3 million private placement and leaned into investor interest around biodefense preparedness. The stock was indicated lower in early premarket quotations Tuesday, after regular trading had not yet resumed. The timing matters. The World Health Organization declared the Ebola Bundibugyo outbreak in Democratic Republic of Congo and Uganda a Public Health Emergency of International Concern, or PHEIC — its top international alert for an event that needs coordinated action, though not necessarily a pandemic. WHO said the
Evolution stock jumps on €2 billion move

Evolution stock jumps on €2 billion move

19 May 2026
Evolution AB shares surged 9% in Stockholm after the company announced a €2 billion share buyback, one of Sweden’s largest. The buyback starts immediately and may run until the 2027 annual meeting, capped at 10% of shares. The OMXS30 index rose just 0.75% in comparison. Evolution also secured a €300 million revolving credit facility from J.P. Morgan SE and Citibank Europe.
NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

19 May 2026
NextEra Energy shares fell 4.6% to $89.04 late Monday after announcing a $66.8 billion stock-led merger with Dominion Energy, whose shares rose 9.4% to $67.56. The deal would create one of the world’s largest electric utilities, serving about 10 million customer accounts and owning 110 gigawatts of generation across four states.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
S&P Global stock slides again as “Mobility Global” spin-off rebrand puts SPGI in the spotlight
Previous Story

S&P Global stock slides again as “Mobility Global” spin-off rebrand puts SPGI in the spotlight

AppLovin stock price slips after hours as CloudX launch and Wedbush target cut put Feb. 11 earnings in play
Next Story

AppLovin stock price slips after hours as CloudX launch and Wedbush target cut put Feb. 11 earnings in play

Go toTop